You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CIN-QUIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cin-quin patents expire, and what generic alternatives are available?

Cin-quin is a drug marketed by Solvay and is included in five NDAs.

The generic ingredient in CIN-QUIN is quinidine sulfate. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the quinidine sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cin-quin

A generic version of CIN-QUIN was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CIN-QUIN?
  • What are the global sales for CIN-QUIN?
  • What is Average Wholesale Price for CIN-QUIN?
Summary for CIN-QUIN
US Patents:0
Applicants:1
NDAs:5
Raw Ingredient (Bulk) Api Vendors: 104
Patent Applications: 4,020
DailyMed Link:CIN-QUIN at DailyMed
Drug patent expirations by year for CIN-QUIN

US Patents and Regulatory Information for CIN-QUIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay CIN-QUIN quinidine sulfate CAPSULE;ORAL 085296-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay CIN-QUIN quinidine sulfate TABLET;ORAL 084932-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay CIN-QUIN quinidine sulfate CAPSULE;ORAL 085297-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay CIN-QUIN quinidine sulfate TABLET;ORAL 085299-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay CIN-QUIN quinidine sulfate TABLET;ORAL 085298-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.